Alpha Tau Medical Ltd
DRTSHealthcare|Biotechnology|IL
$13.72
+0.42 (+3.16%)
Tangible Book / Share
$0.48
Cash / Share
$1.11
Clinical Trials (30)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06202118 A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. | Breast Cancer, Recurrent Breast Cancer | N/A | Recruiting | 10 | Open-label | — |
| NCT06698458 Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer | Pancreatic Cancer, Pancreatic Adenocarcinoma | N/A | Active | 50 | Open-label | — |
| NCT05632913 Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer | Recurrent Lung Cancer, Lung Cancer | N/A | Recruiting | 10 | Open-label | — |
| NCT06026943 Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer | Pancreatic Cancer, Unresectable Pancreatic Cancer | N/A | Recruiting | 15 | Open-label | — |
| NCT06755359 Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer | Pancreatic Cancer, Locally Advanced Pancreatic Cancer | N/A | Recruiting | 40 | Open-label | — |
| NCT05323253 Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma | N/A | Active | 86 | Open-label | — |
| NCT05781555 Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors | Malignant Tumor | N/A | Recruiting | 100 | Open-label | — |
| NCT04002479 Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer | Pancreatic Cancer, Unresectable Pancreatic Cancer | N/A | Active | 37 | Open-label | — |
| NCT05047094 Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC | Head and Neck Squamous Cell Carcinoma, Skin Cancer | N/A | Recruiting | 48 | Open-label | Pembrolizumab |
| NCT05829291 Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver Metastases | Liver Metastases | N/A | Recruiting | 10 | Open-label | — |
| NCT03737734 Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) | Skin Cancer, Mucosal Neoplasm of Oral Cavity | N/A | Active | 30 | Open-label | — |
| NCT03889899 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | Skin Cancer, Mucosal Neoplasm of Oral Cavity | N/A | Recruiting | 30 | Open-label | — |
| NCT04534127 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | Skin Cancer, Mucosal Neoplasm of Oral Cavity | N/A | Recruiting | 56 | Open-label | — |
| NCT04068155 Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors | Skin Cancer, Cutaneous Tumor | N/A | Recruiting | 80 | Open-label | — |
| NCT05657743 Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety) | Pancreatic Cancer, Unresectable Pancreatic Cancer | N/A | Recruiting | 15 | Open-label | — |
| NCT06910306 Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma | Recurrent Glioblastoma, Recurrent Gliomas | N/A | Recruiting | 10 | Open-label | — |
| NCT06202248 Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer. | Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer | N/A | Recruiting | 10 | Open-label | — |
| NCT06615635 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients | Squamous Cell Carcinoma, Alpha Radiation | N/A | Recruiting | 28 | Open-label | — |
| NCT04540588 Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | Skin Cancer, Mucosal Neoplasm of Oral Cavity | N/A | Completed | 2 | Open-label | — |
| NCT04543903 Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer | Prostate Adenocarcinoma | N/A | Completed | 1 | Open-label | — |
| NCT04377360 Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors | Malignant Skin Tumor, Soft Tissue Tumor, Malignant | N/A | Completed | 10 | Open-label | — |
| NCT04761146 A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer | Vulva Cancer, Recurrent, Vulvar Squamous Cell Carcinoma | N/A | Unknown | 10 | Open-label | — |
| NCT06202339 Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT). | Carcinoma of the Vulva, Recurrent Carcinoma of the Vulva | N/A | Not Yet Recruiting | 10 | Open-label | — |
| NCT03886181 Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | Skin Cancer, Mucosal Neoplasm of Oral Cavity | N/A | Terminated | 2 | Open-label | — |
| NCT05065346 Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC | Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma | N/A | Unknown | 79 | Open-label | — |
| NCT03015883 Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma | Squamous Cell Carcinoma | N/A | Completed | 28 | Open-label | — |
| NCT05125354 A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT | Squamous Cell Carcinoma, DaRT Treated Patients | Completed | 33 | — | — | |
| NCT03353077 Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT) | Skin Squamous Cell Carcinoma | N/A | Completed | 28 | Open-label | — |
| NCT07290998 Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer | Prostate Cancer, Recurrent Prostate Cancer | N/A | Not Yet Recruiting | 12 | Open-label | — |
| NCT03970967 Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases | Breast Carcinoma, Metastatic Breast Cancer | N/A | Terminated | 1 | Open-label | — |